As the biopharmaceutical industry faces declining productivity and innovation, personalized medicine offers promise for increasing economic returns, according to “Assessing Risk and Return: Personalized Medicine Development & New Innovation Paradigm.”
Read MoreThe intellectual property (IP) system in the US must be transformed if it is to foster biotechnological advances, national and international IP and biotech leaders said today.
Read MoreExisting recommendations for treating vitamin D deficiency in children with cystic fibrosis are too low to cover the serious need, leaving most at high risk for bone loss and rickets, according to researchers at Johns Hopkins Childrens Center.
Read More
PCR-based assays deliver speed and accuracy, and see increasing adoption in the clinical lab.
Read MoreA major study from a team of researchers from Weill Cornell Medical College and Massachusetts General Hospital has found that a recent change to HIV-treatment guidelines recommending genetic screening is cost-effective under certain conditions. The new recommendation suggests conducting a genetic screening test prior to prescribing the drug abacavir, one of the preferred first-line drugs for the treatment for HIV-infected adults.
Read More